H Olsson|A Borg - JoVE Visualize

Showing results (21-30 of 710) with videos related to

Pageof 71

Sort By:

Oncogene|January 1, 1991

ERBB2 amplification in breast cancer with a high rate of proliferationA Borg, B Baldetorp, M Fernö, et al.

British Journal of Cancer|November 26, 1999

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer riskO Bratt, A Borg, U Kristoffersson, et al.

Cancer Research|April 16, 1998

BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the diseaseK Haraldsson, N Loman, Q X Zhang, et al.

AIDS Research and Human Retroviruses|April 10, 1997

Transcription of human endogenous retroviral sequences related to mouse mammary tumor virus in human breast and placenta: similar pattern in most malignant and nonmalignant breast tissuesH Yin, P Medstrand, M L Andersson, et al.

Cancer|July 21, 1998

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genesN Loman, O Johannsson, P O Bendahl, et al.

Medical Oncology and Tumor Pharmacotherapy|January 1, 1986

A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancerH Olsson, A Borg, S B Ewers, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1990

Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study GroupM Fernö, A Borg, U Johansson, et al.

The New England Journal of Medicine|April 12, 1990

Indicators of prognosis in node-negative breast cancerH Sigurdsson, B Baldetorp, A Borg, et al.

Melanoma Research|December 3, 2002

Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation familiesA Måsbäck, H Olsson, J Westerdahl, et al.

Cancer Letters|June 30, 1994

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancerA Borg, B Baldetorp, M Fernö, et al.

Pageof 71

Showing results (21-30 of 710) with videos related to

Sort By:

Pageof 71

Oncogene|January 1, 1991

ERBB2 amplification in breast cancer with a high rate of proliferationA Borg, B Baldetorp, M Fernö, et al.

British Journal of Cancer|November 26, 1999

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer riskO Bratt, A Borg, U Kristoffersson, et al.

Cancer Research|April 16, 1998

BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the diseaseK Haraldsson, N Loman, Q X Zhang, et al.

AIDS Research and Human Retroviruses|April 10, 1997

Transcription of human endogenous retroviral sequences related to mouse mammary tumor virus in human breast and placenta: similar pattern in most malignant and nonmalignant breast tissuesH Yin, P Medstrand, M L Andersson, et al.

Cancer|July 21, 1998

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genesN Loman, O Johannsson, P O Bendahl, et al.

Medical Oncology and Tumor Pharmacotherapy|January 1, 1986

A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancerH Olsson, A Borg, S B Ewers, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1990

Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study GroupM Fernö, A Borg, U Johansson, et al.

The New England Journal of Medicine|April 12, 1990

Indicators of prognosis in node-negative breast cancerH Sigurdsson, B Baldetorp, A Borg, et al.

Melanoma Research|December 3, 2002

Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation familiesA Måsbäck, H Olsson, J Westerdahl, et al.

Cancer Letters|June 30, 1994

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancerA Borg, B Baldetorp, M Fernö, et al.

Pageof 71